PureTech Health (PRTC) Shares Outstanding (2020 - 2025)
PureTech Health (PRTC) reported Shares Outstanding of $241.7 million for Q4 2025, up 0.95% year-over-year from $239.4 million in Q4 2024, and up 0.95% on a QoQ basis from $239.4 million in Q4 2024.
PureTech Health (PRTC) has 5 years of Shares Outstanding data on file, last reported at $241.7 million in Q4 2025.
- Quarterly Shares Outstanding rose 0.95% year-over-year to $241.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $241.7 million (up 0.95% YoY) and the FY2025 annual result came in at $241.7 million, up 0.95% from the prior year.
- Shares Outstanding advanced to $241.7 million in Q4 2025 per PRTC's latest filing, from $239.4 million in the prior quarter.
- Across five years, Shares Outstanding topped out at $287.8 million in Q4 2021 and bottomed at $239.4 million in Q4 2024.
- The 4-year median for Shares Outstanding is $260.1 million (2022), against an average of $261.9 million.
- The widest annual swing landed in 2022, when Shares Outstanding dropped 3.21%; it then rose 0.95% in 2025.
- Tracing PRTC's Shares Outstanding over 4 years: stood at $287.8 million in 2021, then decreased by 3.21% to $278.6 million in 2022, then retreated by 14.05% to $239.4 million in 2024, then grew by 0.95% to $241.7 million in 2025.
- Per Business Quant, the three latest PRTC Shares Outstanding figures stand at $241.7 million (Q4 2025), $239.4 million (Q4 2024), and $278.6 million (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 5.21 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 56.35 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 91.57 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 254.16 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.80 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 133.44 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 241.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 241.68 Mn |
| Dec 31, 2025 | 241.68 Mn |
| Dec 31, 2025 | 241.68 Mn |
| Dec 31, 2025 | 241.68 Mn |
| Dec 31, 2025 | 241.68 Mn |
| Dec 31, 2025 | 241.68 Mn |
| Dec 31, 2025 | 241.68 Mn |
| Dec 31, 2025 | 241.68 Mn |
| Dec 31, 2024 | 239.42 Mn |
| Dec 31, 2024 | 239.42 Mn |
| Dec 31, 2024 | 239.42 Mn |
| Dec 31, 2024 | 239.42 Mn |
| Dec 31, 2024 | 239.42 Mn |
| Dec 31, 2024 | 239.42 Mn |
| Dec 31, 2024 | 239.42 Mn |
| Dec 31, 2024 | 239.42 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2020 | 285.89 Mn |
| Dec 31, 2020 | 285.89 Mn |
| Dec 31, 2020 | 285.89 Mn |
| Dec 31, 2020 | 285.89 Mn |
| Dec 31, 2020 | 285.89 Mn |
| Dec 31, 2020 | 285.89 Mn |
| Dec 31, 2020 | 285.89 Mn |
| Dec 31, 2020 | 285.89 Mn |